Navigation Links
Accuray Announces Results for Fourth Quarter and Fiscal Year 2012
Date:9/6/2012

SUNNYVALE, Calif., Sept. 6, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the fourth quarter and fiscal year ended June 30, 2012. The fiscal 2012 financial data presented below reflects Accuray's consolidated results including the results for TomoTherapy Incorporated, which was acquired by Accuray in June 2011. Non-GAAP results are provided to enhance understanding of Accuray's ongoing core results of operations.

Highlights from the fourth quarter of fiscal 2012 include continued improvement in service margins, with a year-over-year decrease in sales and marketing, and general and administrative expenses and a 1.15 book-to-bill ratio.

"We have been investing heavily in research and development and plan to introduce two advanced technology platforms at the American Society for Radiation Oncology's (ASTRO) Annual Meeting in October 2012 which we expect to drive future orders and revenue growth," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray. "After the new product introductions we plan to reduce our research and development expenses to more normalized levels as seen historically.  We believe we are on track to return to profitability (non-GAAP) on schedule, by the end of our current fiscal year, ending June 30, 2013."

For the fourth quarter of fiscal 2012, Accuray reported total consolidated GAAP revenue of $100.5 million and non-GAAP total revenue of $101.1 million. By comparison, for the fourth quarter of fiscal 2011, the sum of the revenue reported or recorded by Accuray and TomoTherapy as separate companies totaled $109.8 million on a pro forma basis. For the fiscal year ended June 30, 2012, GAAP revenue was $409.2 million and non-GAAP revenue was $401.3 million, a decrease from the pro forma total revenue of $409.7 million in th
'/>"/>

SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference
2. Accuray to Acquire Morphormics, Inc.
3. Accuray and Erasmus Medical Center Sign Master Research and Collaboration Agreement
4. One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
5. Accuray Rolls Out Comprehensive Customer Service Program in Japan
6. Accuray Incorporated to Speak at Wells Fargo Healthcare Conference
7. Accuray Incorporated to Speak at Jefferies Global Healthcare Conference
8. Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
9. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
10. Accuray Announces Results for Third Quarter Fiscal 2012
11. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... DRRX ) announced today financial results for the second ... loss was $5.5 million for the three months ended June ... and net loss of $5.5 million for the three months ... and investments of $37.8 million, compared to cash and investments ... 2015, we had $19.8 million in long term debt. ...
(Date:8/3/2015)... PARSIPPANY, N.J. , Aug. 3, 2015  LEO ... and Drug Administration (FDA) to include psoriasis as one ... Focused Drug Development Initiative i .  Psoriasis is an ... lives and subsequent comorbidities, affecting 7.5 million people in ... of LEO Pharma,s ongoing commitment to supporting patients living ...
(Date:8/3/2015)... N.Y. , Aug. 3, 2015 ... Wilmot Cancer Institute to the OmniSeq SM ... Roswell Park Cancer Institute (RPCI) and announced it ... that support a physician-driven, collaborative approach to genomic ... outcomes.  Wilmot Cancer Institute is a rapidly expanding, ...
Breaking Medicine Technology:DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 2LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 3OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3
... Researchers at Brigham and Women,s,Hospital found that patients taking ... effects were unrelated to relief from their pain,symptoms. ... examine the addictive,potential of this class of pain medicine, ... 25th Annual Meeting. , In ...
... Lethal ,Super, Strains of C.difficileCHICAGO, Jan. 28 ... scientists at The University of Nottingham are leading a ... one of the most lethal strains of hospital acquired ... technology developed in Nottingham to study the function of ...
Cached Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... other long-term care facilities, today announced details of the Advanced level of their ... centers. , Providigm’s QAPI Accreditation program , introduced in 2013, is based ...
(Date:8/4/2015)... Vegas, Nevada (PRWEB) , ... August 04, 2015 ... ... FEMALE, a striking contemporary look at unique artistic expressions from a diverse group ... inside the Life Is Beautiful Music & Art Festival on September 25-27, 2015 ...
(Date:8/4/2015)... D.C. (PRWEB) , ... August ... ... that its HealthCenter personal health record (PHR) product has achieved Office of ... and Inpatient EHR Certification from Drummond Group. HealthCenter delivers the highest quality ...
(Date:8/4/2015)... ... August 04, 2015 , ... Driving skills may ... to driving, says the August 2015 Harvard Health Letter. , "Age and health ... requires an individual assessment of skills," says Lissa Kapust, a social worker at ...
(Date:8/4/2015)... ... August 04, 2015 , ... METTLER TOLEDO has announced ... featuring researchers from Lubrizol, Pfizer, and Merck. This free online seminar will ... project timelines often require informed decisions with limited process understanding. Established methods ...
Breaking Medicine News(10 mins):Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2
... ... conducted by the US Department of Health and Human Services. , ... Austin, TX (PRWEB) September 25, 2009 -- RCRC Independent ... will provide oversight of research supported or conducted by a federal department or agency within ...
... and weight are shaped by their social class, according to ... Policymakers have long insisted on the importance of ... the first study to show how everyday practices and perceptions ... weight and health of teenagers. ,It is evident that ...
... says it will review procedure for endorsing medical devices ... Food and Drug Administration violated procedures last year when ... own scientists recommended against approval, agency officials said Thursday. ... Jersey-based ReGen Biologics and is used to help surgically ...
... SAN FRANCISCO, CA SEPTEMER 24, 2009 Results ... that the combination of giving patients clopidogrel, a blood ... stomach medicines such as omeprazole, known as proton pump ... some prior studies had suggested. The results were presented ...
... , , NEW YORK, Sept. ... Ashoka will partner to create the first international fellowship program ... improve maternal health in developing countries. The Maternal Health Task ... Maternal Health Program as a commitment to action at the ...
... , , , ... Health Registry is expanding its service area across Oklahoma by partnering ... Web service on November 1st, 2009. , , ... has nearly doubled from 1.3 million people served by the Emergency ...
Cached Medicine News:Health News:RCRC Independent Review Board Announces DHHS Research Oversight 2Health News:Social background weighs heavily on teenage diet 2Health News:FDA Acknowledges Mistakes in Knee-Device Approval 2Health News:Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 2Health News:Building the Next Generation of Global Leaders - Maternal Health Task Force and Ashoka Partner 2Health News:Building the Next Generation of Global Leaders - Maternal Health Task Force and Ashoka Partner 3Health News:Oklahoma Medics Embracing iB Web Service 2
... Designed specifically to ... interventionalists, Sequitor facilitates the ... the peripheral vasculature for ... both uterine fibroid embolization ...
Reference Lab Interface (RLI)© for SRS Software, provides real-time processing of HL7 lab data directly into SRS Freedom Chart ManagerTM, producing an HTML form in the patients chart/tab, whil...
... technology innovation, the new Guidant VASOVIEW® 7 ... the VASOVIEW® platform. The new VASOVIEW® 7 ... familiar platform, combining ease of use with ... finesse into a proven system. Discover advanced ...
Patient Monitor...
Medicine Products: